Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 41 min ago
Peer-reviewedLicence not statedCirculation research

GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight

  • Tapan A Patel1
  • Jill Rose1
  • Kenichi Katsurada2,3
  • Toshihiko Yada4,5,6
  • Panagiotis Koutakis1
  • Jeffrey Salomon1,7
  • Kaushik P. Patel1
  • Mabruka Alfaidi1,8
8 affiliations
  1. 1Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  2. 2Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Japan.
  3. 3Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University, Japan.
  4. 4Division of Integrative Physiology, Center for Integrative Physiology, Kansai Electric Power Medical Research Institute, Kyoto, Japan.
  5. 5Department of Diabetes, Endocrinology and Metabolism/Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
  6. 6Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan.
  7. 7Department of Pediatrics, Children’s Nebraska, Child Health Research Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  8. 8Center for Heart and Vascular Research, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Read full textPDFDOICite

Related

  1. Clinical Evaluation of Biased μ-Opioid Receptor Agonists: A Narrative Comparative Review from Oliceridine to Tegileridine and Mechanistic Reappraisal.
    Houren Xu, Yu Wang, Na Hu +3
    Drug design, development and therapyPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMCPMC
  2. Balancing the benefits and risks of GLP-1 receptor agonists: a clinical guide for shared decision-making
    Areesha Moiz, Tricia M. Peters, Michael A. Tsoukas +3
    EClinicalMedicinePeer-reviewedCC BY-NCFull text11 citedEndocrinology & metabolismOpenAlex
  3. GLP‐1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications
    Peter Ueda
    Journal of Internal MedicinePeer-reviewedCC BY 4.0Full textEndocrinology & metabolismPMC
  4. Glucagon-Like Peptide-1 Receptor Agonists and the Eye: Ocular Safety, Retinal Outcomes, and Clinical Implications
    Gwi Eun Yeo, Joonhyung Kim
    Journal of Korean medical sciencePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  5. Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials
    Massimo Nardone, Luxcia Kugathasan, Lauren Daunt +7
    eClinicalMedicinePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{patel2026glp1,
  title = {{GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight}},
  author = {Tapan A Patel and Jill Rose and Kenichi Katsurada and Toshihiko Yada and Panagiotis Koutakis and Jeffrey Salomon and Kaushik P. Patel and Mabruka Alfaidi},
  journal = {Circulation research},
  year = {2026},
  month = jul,
  doi = {10.1161/circresaha.126.327683},
  url = {https://doi.org/10.1161/circresaha.126.327683},
}
RIS
TY  - JOUR
TI  - GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
AU  - Tapan A Patel
AU  - Jill Rose
AU  - Kenichi Katsurada
AU  - Toshihiko Yada
AU  - Panagiotis Koutakis
AU  - Jeffrey Salomon
AU  - Kaushik P. Patel
AU  - Mabruka Alfaidi
PY  - 2026
DA  - 2026/07/16
JO  - Circulation research
DO  - 10.1161/circresaha.126.327683
UR  - https://doi.org/10.1161/circresaha.126.327683
SN  - 0009-7330
SN  - 1524-4571
ER  -